Caremark to pay $38.5M settlement

Pharmacy benefit manager Caremark Rx has agreed to pay a total of $38.5 million to 28 states and the District of Columbia to settle charges that it manipulated doctors into changing prescriptions that favored the company. The investigation concluded that Caremark convinced doctors to switch their patients over to specific brand-name medications without disclosing its own financial interest in their doing so. Caremark, which is admitting no wrongdoing, allegedly twisted doctors' arms because it was getting big volume discounts on the drugs it was pitching. As part of the settlement, Caremark has agreed to follow terms of a prescription fulfillment policy which, among other things, forbids it from recommending drug changes if the proposed drug will cost consumers or employers more than the originally-prescribed drug.

To learn more about the settlement:
- read this Modern Healthcare article (reg. req.)

Related Articles:
Caremark settles whistleblower suit for $137.5 million. Report
CVS to acquire Caremark Rx. Report

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.